Sweden· SE-20081003000031
Enyglid 2 mg Tablett
A medicinal product containing repaglinide, registered in Sweden by Krka d.d., Novo mesto.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Repaglinide
- Manufacturer
- Krka d.d., Novo mesto
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20081003000031
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Repaglinide in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENYGLIDKrka, d.d., Novo mesto, Novo mesto
- United KingdomEnyglid 2mg tabletsKrka UK Ltd
- SpainEnyglid 2 mg comprimidos EFGKrka D.D. Novo Mesto
- FranceNOVONORM 2 mg, compriméNOVO NORDISK (DANEMARK)
- ItalyNOVONORMNOVO NORDISK A/S
- FinlandEnyglidKRKA d.d. Novo mesto
- NetherlandsEnyglid 2 mg, tabletsKrka d.d., Novo mesto
- United StatesRepaglinideRising Pharma Holdings, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Repaglinid Ratiopharm, Repaglinid Sandoz
- Belgium · Repaglinide Eg
- Bulgaria · Индорин
- Cyprus · Theroflan
- Czechia · Vatinid
- Germany · Repaglinid 1 A Pharma, Repaglinid Abz
- Denmark · Repaglinid Doc Generici
- Spain · Repaglinida Alter, Repaglinida Aurovitas
- Finland · Repaglinid Stada
- France · Repaglinide Arrow Lab, Repaglinide Biogaran
- United Kingdom (Northern Ireland) · Repaglinide, Repaglinide Rivopharm Uk
- Greece · Theroflan
- Croatia · Reglinid, Repaglinid Pharmas
- Iceland · Enyglid, Novonorm
- Italy · Glicam, Repaglinide Aurobindo
- Liechtenstein · Repaglinide Teva
- Luxembourg · Repaglinide Eg
- Latvia · Repaglinide Elvim
- Malta · Repaglinide Aurobindo
- Netherlands · Repaglinide Stada
- Norway · Enyglid, Novonorm
- Romania · Reneos, Repaglinida Arena
- Slovenia · Repaglinid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0a91983d-2467-4691-bdbf-d86c16604cf3 GET /v1/drugs/0a91983d-2467-4691-bdbf-d86c16604cf3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20081003000031",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20081003000031",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/enyglid-epar-product-information_sv.pdf"
}See everything about repaglinide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.